Analysts for Raymond James and Lake Street Capital Markets say the CMS Final Rule released last evening is a win for Profound Medical (NASDAQ:PROF; TSX:PRN), confirming “very strong reimbursement” for the company’s...
Profound Medical (NASDAQ: PROF; TSX: PRN) has seen the first MRI-guided prostate cancer treatment performed using its TULSA-PRO system at the Mātai Medical Research Institute in Gisborne, New Zealand, following its...
Profound Medical (NASDAQ: PROF; TSX: PRN) has announced that it has entered into a supply and distribution agreement with the iMRI Division of closely held Cook Medical to expand U.S. sales of its TULSA-PRO system...
Profound Medical (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) announced that Emmy Award-winning television host, health advocate and decorated U.S. Navy veteran, Montel Williams, will join the next Let’s Huddle...
Profound Medical (NASDAQ:PROF; TSX:PRN) has announced that five abstracts presented at the 15th Interventional MRI (iMRI) Symposium in Boston, Massachusetts, reinforce the growing body of evidence supporting the real...
Profound Medical (NASDAQ:PROF; TSX:PRN) and Telix Pharmaceuticals (ASX:TLX; NASDAQ:TLX) have entered into a co-education agreement which establishes a framework through which the companies intend to educate urologists...
Profound Medical (NASDAQ: PROF; TSX: PRN) announced preliminary unaudited revenues for the third quarter of 2026. The company indicated that its: Total revenue is expected to be in the range of $9.8 million to $10.0...
According to a filing with SEDI, Profound Medical (NASDAQ:PROF; TSX:PRN) president, Richard Fabian, acquired a total of 10,000 shares of Profound on the open market today at a cost of $59,800 (U.S.). In a sign of...
Titan Partners initiated coverage of Profound Medical (NASDAQ:PROF; TSX:PRN) with a “buy” rating and price target of $12.00. The stock closed at $5.96 on Sept 10. Profound is a commercial-stage medical device company...
Profound Medical (NASDAQ: PROF; TSX: PRN) has appointed Richard Fabian as president, effective immediately, succeeding Mathieu Burtnyk, PhD, who has assumed the newly created position of chief technology officer. Mr...